Poor central nervous system penetration of tigecycline in a patient with sepsis and ventriculitis caused by multidrug-resistant Klebsiella pneumoniae

Journal of Pharmacy Technology

Volumn 23, Issue 6, 2007, Pages 344-348

  Chen, Julie L ^a   Orsini, Jose ^a   Killu, Claude ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; GENTAMICIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN VENTRICULITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DRUG MEGADOSE; DRUG PENETRATION; HEART INFARCTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MALE; SEPSIS;

EID: 36849064430     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250702300604     Document Type: Article

References (15)

1. Weinstein RA. Nosocomial infection update. Emerg Infect Dis 1998;4:416-20.
2. US Department of Public Health and Human Services. National Nosocomial Infections Surveillance (NNIS) System Report: data summary from January through June 2004. October 2004. Am J Infect Control 2004;32:470-85.
3. Ziai WC, Lewin JJ. Advances in the management of central nervous system infections in the ICU. Crit Care Clin 2007;22:661-94.
4. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
5. Package insert. Tygacil (tigecycline). Philadelphia, PA: Wyeth Pharmaceuticals Inc., 2005.
6. Squires RA, Postier RG. Tigecycline for the treatment of infections due to resistant gram-positive organisms. Expert Opin Investig Drugs 2006;15:155-62.
7. Zhanel GG, Karlowsky JA, Rubinstein E, Hoban DJ. Tigecycline: a novel glycylcycline antibiotic. Expert Rev Anti Infect Ther 2006;4:9-25.
8. Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grossi EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 2006;58:1221-9.
9. Allen JC. Minocycline. Ann Intern Med 1976;85:482-7.
10. Dotevall L, Alestig K, Hanner P, Norkrans G, Hagberg L. The use of doxycycline in nervous system Borrelia burgdorferi infection. Scan J Infect Dis 1988;53(suppl):74-9.
11. Wormser GP, Dattwyler RL, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
12. Moellering RC Jr, Fischer EG. Relationship of intraventricular gentamicin levels to cure of meningitis. Report of a case of Proteus meningitis successfully treated with intraventricular gentamicin. J Pediatr 1972;81:534-7.
13. Saad AF, Farrar WE Jr. Intracisternal and intrathecal injections of gentamicin in Enterobacter meningitis. Arch Intern Med 1974;134:738-40.
14. Turgeon PL, Laverdiere M, Perron L. Successful treatment of Pseudomonas meningitis and septicemia in a leukemic neutropenic adult. Am J Clin Pathol 1975;63:135-41.
15. Li C, Sutherland CA, Nightingale CH, Nicolau DP. Quantitation of tigecycline, a novel glycylcycline by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2004;811:225-9.